Blog

Learn more about Pierian by browsing our resources below!

Our Latest Posts

Filter by Type

Pierian and Genome Medical Announce Collaboration to Optimize Genomic Testing Programs

We are excited to announce our new partnership with Genome Medical,

Pierian and Syapse Collaborate with Health Systems, Leveraging Data to Power Precision Oncology

ST. LOUIS, June 15, 2022 --Pierian®, a global leader in advanced

Enabling Genomics in Practice

There are certain times in your life where a single sentence can

Pierian and Biodesix Partner to Advance Lung Cancer Diagnostics

Partnership enables comprehensive clinical information to deliver

Pierian Closes up to $47.5 Million of Growth Capital

Funds to drive commercial expansion as growing number of facilities

Employee Spotlight: Dr. Gerald Martin

Understanding the human genome has opened up incredible new

Pierian Partners with Florida Cancer Specialists & Research Institute to Advance Cancer Care

Partnership enables local oncology genomic testing to broaden patient

Employee Spotlight: Dr. Renee Sears, Clinical Genomics Specialist

Our Employee Spotlight shines a light on the uniqueness of the

Pierian and Intermountain Healthcare Combine Expertise to Advance Myriad Genetics’ Tumor Test Offering

Comprehensive Genetic Profiling Supplements Germline and Companion

Pierian Hackathon: 2021

“It’s funny what a good hackathon can do,” remarked Ankita Parikh,

Making Genomics the Standard of Care in Community Cancer Centers

According to recent estimates, almost 80% of cancer patients (1,2) in

Pierian Announces the Appointment of Lindsay Mateo as Chief Business Officer

ST. LOUIS, MO., March 2, 2021 — Pierian, the global leader in

Pierian partners with the Belgian Society of Medical Oncology (BSMO) to evaluate potential of comprehensive genomic profiling in late-stage cancer real-world setting across Belgium

BALLETT Study will measure the impact of comprehensive genomic

Pierian Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets

Additional Illumina assays to be combined with the Pierian platform

Pierian and Pillar Biosciences Announce Partnership to Support Precision Cancer Care

Multiple targeted assays from Pillar Biosciences to be combined with

Enabling High-Throughput Comprehensive Genomic Profiling

Comprehensive genomic profiling is emerging as a powerful tool in our

Enabling Targeted Sequencing with Minimal Complexity

Next generation sequencing continues to gain traction as a standard

Voices of Leaders Interview with Rakesh Nagarajan

What is the one thing we must do if we are to give complex disease a

Enabling Liquid Biopsy with Minimal Complexity

Precision medicine continues to gain traction, and increasingly,

Pierian and University Hospital of Augsburg Announce Strategic Partnership

Collaboration will create integrated clinical interpretation and

Cancer in the Time of Coronavirus

Precision medicine is the ability to use genomic information to

The Personalized Diagnostics Podcast

Sequencing technology advances, such as comprehensive profiling

Intermountain Healthcare Selects Pierian Clinical Genomics Solution

Intermountain Healthcare joins Pierian’s partner network to

Pierian Closes Series B Financing Round

Funding led by ATW Partners and SJF Ventures with follow-on

Visit Pierian at ACMG 2019

Pierian will be highlighting germline features of its genomics

Addressing Common Barriers to Clinical NGS Testing

Genomic tests that use next generation sequencing (NGS) technology

Why Are Other Healthcare Institutions Bringing Clinical NGS Testing In-House?

In just under 15 years, next generation sequencing (NGS) has evolved

The Hurdles of Making Clinical Sequencing a Reality

At PierianDx, we are well-versed in helping healthcare organizations

Pierian Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

Comprehensive pan-cancer tumor profiling assays to be combined with

We Know Precision Medicine: Bryce Daines

Precision medicine is the ability to use genomic information to

Join us October 31- November 3 at the Association for Molecular

We Know Precision Medicine: Lisa Owen

Precision medicine is the ability to use genomic information to

Better Integrating Pathology into Cancer Care

In many healthcare settings the important role of pathology is

CAP Distributive Model of NGS Testing

Are you considering offering clinical NGS testing or looking for an

We Know Precision Medicine: Shalini Verma, Laboratory and Medical Director

We Know Precision Medicine is a series of blog posts and articles

A Guide for the Interpretation and Reporting of Sequence Variants in Cancer

Recently we hosted a webinar in which Medical Director, Shalini

We Know Precision Medicine: Andy Bredemeyer, VP Product

"We Know Precision Medicine" is a series of blog posts and articles

Less Variation, More Standardization in Somatic Variant Interpretation and Reporting

Preparing for our upcoming webinar -- A Practice-based Guide for

We Know Precision Medicine: Rakesh Nagarajan

"We Know Precision Medicine" is a series of blog posts and articles

PierianDx Expands to Australia with Addition of Anatomical Pathology PathWest Laboratory Medicine

PierianDx, the leading clinical genomics technology company that

2bPrecise and Pierian Collaborate to Deliver a Comprehensive Precision Medicine Solution

As posted on BusinessWire Combining Patient Genomic and Clinical

PierianDx Hires Healthcare IT, Analytics Pioneer as CEO

MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical

PierianDx Partners with ScienceVision to Bring Robust Precision Medicine Support to Southeast Asia

MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics

University of Alabama takes a Dogged Approach to Precision Medicine

In the U.S. alone, there are nearly 700,000 people living with a

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology companythat

Optimizing the Bioinformatics Output of your Molecular Pathology Lab

One of America’s greatest inventors, Thomas Edison, didn’t invent the

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

PierianDx, the leading genomics technology company that

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

PierianDx named Chris Callahan as the new Chief Commercial Officer to

Cardiology Field Whole-heartedly Ready for Precision Medicine

Cardiovascular disease causes more deaths worldwide than any other

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

PierianDx, the leading clinical genomics technology company that

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

Flashback: the Human Genome Project was launched in 1990 by Nobel

Inova Launches Predictive Phenotyping Study with NIH

In case you missed it, PierianDx customer, Inova, is launching a

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

The drive to deliver precision medicine has galvanized many hospitals

Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity

Life gets better when we enter our "golden years" and retire, doesn’t

PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR

The Moffitt Morsani Molecular Laboratory, located within the Moffitt

PierianDx Showcases Germline Features in CGW at ACMG 2018

PierianDx will be highlighting germline features of its genomics

CMS NCD on Genomic Testing

CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients

When CMS initiated a national coverage analysis for NGS-based testing

Precision Medicine in Canada

We are excited to attend the upcoming Precision Oncology Experimental

PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada

On April 5 and 6 oncology leaders will convene in Calgary, Alberta to

Saving Infants with Genetic Testing

Genetic diseases are the leading cause of death for infants in North

PierianDx Customer Dartmouth-Hitchcock Medical Center Illustrates ALK-Rearranged Lung Cancer Patient Case in CAP Today Article

Laura J. Tafe, MD, associate professor of pathology and laboratory

Precision Medicine to Improve Patient Safety

While healthcare continues to improve, advances in technologies and

HIMSS18 Round-up: Why the Time for Precision Medicine is Now

by Brad Herrick, PierianDx Like most people who have been going to

PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

PierianDx, the leading genomics technology company that

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that

PierianDx Exhibiting at Health Systems Summit

PierianDx will be exhibiting at an intensive one-day summit for CEOs

PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

PierianDx, the leading genomics technology company that

PharmaTech Outlook Spotlights PierianDx in December Issue

PharmaTech Outlook recently featured PierianDx in it’s December 2017

PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

PierianDx announced today two key additions that will expand the

Cleveland Clinic Joins Pierian’s Customer Network to Accelerate Precision Medicine

Pierian announced today that Cleveland Clinic will utilize its

PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170

PierianDx, the forerunner in clinical genomic analysis,

PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs

ST LOUIS – PierianDx, the forerunner in clinical genomic analysis,

Moffitt Cancer Center Showcases its Blueprint for Building a Best-in-Class Precision Medicine Program at PierianDx-hosted Webinar

PierianDx, the forerunner in clinical genomic analysis,

PierianDx Announces Launch of Clinical Interpretation Services at ACMG 2017

New Service Combines Powerful Technology with Medical and Scientific

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point

NEW YORK (GenomeWeb) – Last week, PierianDx announced six new

PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW)

PierianDx announced today that six leading healthcare systems and

University of Vermont Touts the Importance of Clinical Integration to Accelerate Precision Medicine in PierianDx Webinar Series

PierianDx, the forerunner in clinical genomic analysis,

Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

Not long ago, doctors hoping to cure human disease spent a lot of

PierianDx Acquires Tute Genomics

Company Extends Ability to Deliver a Unified Sample-to-Report

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

ST LOUIS – PierianDx, the forerunner in clinical genomic analysis,

PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

ST LOUIS/BOULDER – ArcherDX and PierianDx today announced

PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members

ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

This financing will enable PierianDx to expand its lead as a pioneer

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading

Aeon Clinical Laboratories Leverages Pierian Bioinformatics Platform to Enhance Genomic Test Offering

ST LOUIS, MO/GAINSVILLE, GA – Pierian, the forerunner in clinical

MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

NEW YORK (GenomeWeb) – This summer, PierianDx plans to add a

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

ST LOUIS, MO – PierianDx announced today that its genomic testing

UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data

ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that

Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients

ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

ARUP Laboratories, a national nonprofit reference laboratory,

PierianDx Launches NGS Gateway Program

ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

Washington University is throwing its hat in the clinical sequencing

Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network

ST. LOUIS MO – PierianDx announced today that Moffitt Cancer Center

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

ST. LOUIS, MO – PierianDx announced today that it has exclusively

Journal of Molecular Diagnostics

PierianDx Medical Advisor, Catherine Cottrell, Ph.D., FACMG,

Clinical NGS WUSTL

Rakesh Nagarajan, M.D., PhD., PierianDx Founder and Chief BioMedical